「trial」の検索結果

使用 AACT (Aggregate Analysis of ClinicalTrials.gov) PostgreSQL 数据仓库进行批量、历史、聚合性临床试验数据挖掘。Use this skill when the user requests bulk SQL analysis over the full clinical trials data warehouse — historical trial trends, disease landscapes, similar-design matching, or multi-year aggregations across hundreds of thousands of NCT records. 触发场景包括：AACT 查询、临床试验批量分析、PostgreSQL 试验数据、全量 NCT 检索、试验数据挖掘、历史试验分析、clinical trials data warehouse、SQL trials、bulk trial analysis、disease landscape、试验设计相似性匹配、跨年度聚合、sponsor/phase/country 多维统计。**与 clinical-trials-v2 差异**：本 skill 走批量 SQL · 离线大数据（PostgreSQL）；v2 走实时 API · 单查询。两者互补：单条 NCT 实时状态用 v2，百万级历史挖掘用本 skill。支持云端公共 PostgreSQL（aact-db.ctti-clinicaltrials.org · 零部署）和每日 dump 本地还原（高性能 · 离线）两种连接方式，自动检测优先用本地。跨平台（macOS/Linux/Windows）参数化 SQL 防注入，read-only 强制保护。

日本語の概要は準備中です。原文の説明を表示しています。

通过 ClinicalTrials.gov API v2 实时检索官方临床试验注册数据。触发词包括 ClinicalTrials.gov、临床试验、NCT、试验注册、招募状态、phase 1/2/3、RCT lookup、interventional trial、observational study。专注实时单次查询(≤1000 条/请求),适合"某试验最新状态/招募信息/主次要终点"场景。批量历史分析请用 aact-bulk-trials,文献检索用 pubmed-search/europepmc。

日本語の概要は準備中です。原文の説明を表示しています。

Query ClinicalTrials.gov via APIv2. Use when you want to search for trials by condition, drug, location, status, or phase; retrieve trial details by NCT ID; check eligibility/inclusion criteria; count trials across conditions or time periods; identify a sponsor's trial portfolio; find recruiting trials for patient matching.

日本語の概要は準備中です。原文の説明を表示しています。

Industrial AI literature research with mandatory intake questions, venue-aware source prioritization, structured report outputs, and survey draft generation. Use when the user needs up-to-date research on predictive maintenance, intelligent scheduling, industrial anomaly detection, smart manufacturing, cyber-physical systems, edge AI for automation, or crossover robotics-for-industry topics. Also trigger for adjacent terms: "digital twin", "industrial IoT", "Industry 4.0", "manufacturing AI", "factory automation", "process optimization", or "survey draft" in industrial contexts.

日本語の概要は準備中です。原文の説明を表示しています。

当用户询问 ClinicalTrials.gov / 临床试验 / NCT / 试验注册 / 招募状态 / phase 1/2/3 / RCT lookup / sponsor 检索 / interventional trial / observational study / 主次要终点 / trial outcomes / 试验招募中 / recruiting status 时,通过 ClinicalTrials.gov API v2 实时检索官方注册数据。专注实时单次查询(≤1000 条/请求),典型场景: "某 NCT 试验最新状态"、"BTK 抑制剂 Phase 3 在招募试验"、"某试验已发布的主次要终点结果"。明确边界: 批量 >10k 试验 / 全库 SQL 历史分析 → aact-bulk-trials; 关联 PubMed 文献 → pubmed-eutils; RCT 自动 GRADE 评级 → medical-evidence-grading; 引用入报告附录 → evidence-appendix-sync。跨平台无锁(Claude Code / Codex / Cursor 通用)。

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Build industrial-grade SCADA/HMI dashboards in MATLAB following industrial-HMI conventions (ISA-101-aligned): gray-field philosophy, alarms at source, write safeguards, fixed-range trends, drill-down layout. Produces a real App Designer app (.mlapp, or plain-text .m+.xml on R2026b+) by handing serialization to the matlab-build-app skill when available, and falls back to a programmatic .m app otherwise. Use when wrapping OPC UA / Modbus / MQTT / OSI PI / PI AF monitoring scripts into a live operator app, building plant overviews, designing operator dashboards, or any time a user asks for a "SCADA dashboard", "HMI", "plant dashboard", "operator screen", or "industrial monitoring app" in MATLAB. Trigger on: SCADA, HMI, industrial dashboard, plant overview, operator screen, uigauge, uilamp, alarm banner, gray-field, ISA-101, OPC UA dashboard, setpoint, write safeguards, alarm visualization, OSIsoft PI, AVEVA PI, PI Server, PI Data Archive, PI AF, PI Asset Framework, piclient, afclient.

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Search the ClinicalTrials.gov registry through its version 2 REST API for interventional and observational studies, their phases, enrolment, endpoints, sponsors, and posted results. Use this skill to survey who is developing what against an indication, date a competitor's programme, read primary and secondary outcome measures, find eligibility criteria, and distinguish a study that completed from one that was terminated or withdrawn. Also trigger on ClinicalTrials.gov, NCT number, trial registry, study phase, enrolment, primary outcome measure, recruiting status, trial sponsor, or competitive landscape.

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Expert-level industrial automation covering PLCs, SCADA, industrial networks, safety systems, robot integration, and Industry 4.0 technologies.

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

日本語の概要は準備中です。原文の説明を表示しています。

Query ClinicalTrials.gov via API v2. Search trials by condition, drug, location, status, or phase. Retrieve trial details by NCT ID, export data, for clinical research and patient matching.

日本語の概要は準備中です。原文の説明を表示しています。

Draft a clinical trial protocol synopsis with the elements regulators and IRBs expect. Use when asked to write a clinical trial protocol, a study protocol synopsis, a trial design, or to structure endpoints/eligibility/statistics for an interventional study. Produces a structured protocol synopsis — objectives, design, population with eligibility, interventions, endpoints, statistics, and safety/ethics — for expert review. (For non-clinical/UX research, use research-protocol.)

日本語の概要は準備中です。原文の説明を表示しています。

Generate clinical trial protocols for medical devices or drugs. This skill should be used when users say "Create a clinical trial protocol", "Generate protocol for [device/drug]", "Help me design a clinical study", "Research similar trials for [intervention]", or when developing FDA submission documentation for investigational products.

日本語の概要は準備中です。原文の説明を表示しています。

Generate clinical trial protocols for medical devices or drugs. This skill should be used when users say "Create a clinical trial protocol", "Generate protocol for [device/drug]", "Help me design a clinical study", "Research similar trials for [intervention]", or when developing FDA submission documentation for investigational products.

日本語の概要は準備中です。原文の説明を表示しています。

Query ClinicalTrials.gov via API v2. Search trials by condition, drug, location, status, or phase. Retrieve trial details by NCT ID, export data, for clinical research and patient matching.

日本語の概要は準備中です。原文の説明を表示しています。

Query ClinicalTrials.gov API v2 for trial data. Search by condition, drug/intervention, location, sponsor, or phase; fetch details by NCT ID; filter by status; paginate; export CSV. For clinical research, patient matching, and trial portfolio analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Clinical-trial readout analysis: pull the trial, evaluate the readout with AdCom-style scrutiny (endpoints, statistics, subgroups, missing data, safety, tolerability/persistence), place it in a cross-trial comparison lattice vs SoC and class peers, and size the stock reaction with historical grounding. The judgment core for binary biotech events.

日本語の概要は準備中です。原文の説明を表示しています。

Query ClinicalTrials.gov via API v2. Search trials by condition, drug, location, status, or phase. Retrieve trial details by NCT ID, export data, for clinical research and patient matching.

日本語の概要は準備中です。原文の説明を表示しています。

Comprehensive legal applications skill covering civil/criminal/administrative litigation workflows, trial defense strategies, legal document drafting (complaints, answers, appeals, retrial petitions, enforcement applications, representation opinions, defense statements, legal opinions, etc.), arbitration (commercial & labor), mediation, enforcement procedures, evidence rules, and litigation risk assessment. Trigger when users ask about: lawsuit/litigation/trial, legal documents, court defense, evidence/cross-examination, arbitration, enforcement, legal strategy, filing a case, appeal, retrial, representation, pleading, or any legal procedural guidance.

日本語の概要は準備中です。原文の説明を表示しています。

使用 AACT (Aggregate Analysis of ClinicalTrials.gov) PostgreSQL 数据库进行大批量临床试验历史分析与数据挖掘。触发场景包括：AACT 查询、临床试验批量分析、PostgreSQL 试验数据、全量 NCT 检索、试验数据挖掘、clinical trials data warehouse、疾病领域全景分析、设计相似试验匹配、跨年度试验趋势聚合。本 skill 通过 SQL 接口处理百万级试验记录，支持云端公共 PostgreSQL 服务（aact-db.ctti-clinicaltrials.org）和每日 dump 本地还原两种连接方式，自动检测并优先使用本地高性能模式。

日本語の概要は準備中です。原文の説明を表示しています。